8TZM

Solution structure for a putative Type I site-specific deoxyribonuclease from Neisseria gonorrhoeae (NCCP11945). Seattle Structural Genomics Center for Infectious Disease target NegoA.19201.a

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-13C HSQC	0.8 mM [U-99% 13C; U-99% 15N] N1, 100 mM sodium chloride, 20 mM TRIS, 1 mM DTT	93% H2O/7% D2O	120 mM	7	1 atm	293	Agilent VNMRS 600
2	2D 1H-13C HSQC aliphatic	0.8 mM [U-99% 13C; U-99% 15N] N1, 100 mM sodium chloride, 20 mM TRIS, 1 mM DTT	93% H2O/7% D2O	120 mM	7	1 atm	293	Agilent VNMRS 600
3	2D 1H-13C HSQC aromatic	0.8 mM [U-99% 13C; U-99% 15N] N1, 100 mM sodium chloride, 20 mM TRIS, 1 mM DTT	93% H2O/7% D2O	120 mM	7	1 atm	293	Agilent VNMRS 600
4	2D 1H-15N HSQC	0.8 mM [U-99% 13C; U-99% 15N] N1, 100 mM sodium chloride, 20 mM TRIS, 1 mM DTT	93% H2O/7% D2O	120 mM	7	1 atm	293	Agilent VNMRS 600
5	2D 1H-15N HSQC	0.8 mM [U-99% 15N] N1, 100 mM sodium chloride, 20 mM TRIS, 1 mM DTT	100% D2O	120 mM	7	1 atm	293	Agilent VNMRS 600
16	2D 1H-13C HSQC	0.5 mM [U-10% 13C; U-99% 15N] N1, 100 mM sodium chloride, 20 mM TRIS, 1 mM DTT	93% H2O/7% D2O	120 mM	7	1 atm	293	Bruker AVANCE III 700
15	3D 1H-13C NOESY aliphatic	0.8 mM [U-99% 13C; U-99% 15N] N1, 100 mM sodium chloride, 20 mM TRIS, 1 mM DTT	93% H2O/7% D2O	120 mM	7	1 atm	293	Agilent VNMRS 600
14	3D 1H-13C NOESY aromatic	0.8 mM [U-99% 13C; U-99% 15N] N1, 100 mM sodium chloride, 20 mM TRIS, 1 mM DTT	93% H2O/7% D2O	120 mM	7	1 atm	293	Agilent VNMRS 600
13	3D 1H-15N NOESY	0.8 mM [U-99% 13C; U-99% 15N] N1, 100 mM sodium chloride, 20 mM TRIS, 1 mM DTT	93% H2O/7% D2O	120 mM	7	1 atm	293	Agilent VNMRS 600
11	3D CBCA(CO)NH	0.8 mM [U-99% 13C; U-99% 15N] N1, 100 mM sodium chloride, 20 mM TRIS, 1 mM DTT	93% H2O/7% D2O	120 mM	7	1 atm	293	Agilent VNMRS 600
10	3D CBCA(CO)NH	0.8 mM [U-99% 13C; U-99% 15N] N1, 100 mM sodium chloride, 20 mM TRIS, 1 mM DTT	93% H2O/7% D2O	120 mM	7	1 atm	293	Agilent VNMRS 600
9	3D C(CO)NH	0.8 mM [U-99% 13C; U-99% 15N] N1, 100 mM sodium chloride, 20 mM TRIS, 1 mM DTT	93% H2O/7% D2O	120 mM	7	1 atm	293	Agilent VNMRS 600
8	3D HNCA	0.8 mM [U-99% 13C; U-99% 15N] N1, 100 mM sodium chloride, 20 mM TRIS, 1 mM DTT	93% H2O/7% D2O	120 mM	7	1 atm	293	Agilent VNMRS 600
7	3D HCCH-TOCSY	0.8 mM [U-99% 13C; U-99% 15N] N1, 100 mM sodium chloride, 20 mM TRIS, 1 mM DTT	93% H2O/7% D2O	120 mM	7	1 atm	293	Agilent VNMRS 600
6	3D HNCO	0.8 mM [U-99% 13C; U-99% 15N] N1, 100 mM sodium chloride, 20 mM TRIS, 1 mM DTT	93% H2O/7% D2O	120 mM	7	1 atm	293	Agilent VNMRS 600

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Agilent	VNMRS	600
2	Bruker	AVANCE III	700

NMR Refinement
Method	Details	Software
torsion angle dynamics	STRUCTURE DETERMINATION WAS PERFORMED ITERATIVELY USING CYANA (AUTOMATED NOESY ASSIGNMENTS). A TOTAL OF 20 STRUCTURES OUT OF 100 WITH LOWEST TARGET FUNCTION FROM THE FINAL CYANA CALCULATION WERE TAKEN AND REFINED BY RESTRAINED MOLECULAR DYNAMICS/ENERGY MINIMIZATION IN EXPLICIT WATER (CNS) AFTER ADDING 0% TO THE UPPER BOUNDARY LIMIT OF THE DISTANCE RESTRAINTS AND THE VDW	CNS

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (target function)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	Felix	2017	Accelrys Software Inc.
2	structure calculation	CYANA	2.1	Guntert, Mumenthaler and Wuthrich
3	refinement	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
4	data analysis	PSVS	1.5	Bhattacharya and Montelione
5	data analysis	TALOS+		Cornilescu, Delaglio and Bax
6	data analysis	Poky		Manthey, Tonelli, Clos II, Rahimi, Markley, Lee

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.